Covid-19 Treatment Market

Patients today have more treatment options in the battle against coronavirus disease.

In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.

The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.

The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.

In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.

In Covid-19 Treatment Market , we study all treatment method for Covid-19.
Covid-19 Treatment Market aims to provide a comprehensive presentation of the global market for Covid-19 Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Treatment. Covid-19 Treatment Market contains market size and forecasts of Covid-19 Treatment in global, including the following market information:
Global Covid-19 Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Covid-19 Treatment market was valued at US$ 14310 million in 2022 and is projected to reach US$ 18030 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core covid-19 treatment manufacturers include Cadila Healthcare, Novartis etc.The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.
We surveyed the Covid-19 Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Covid-19 Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Covid-19 Treatment Market Segment Percentages, by Type, 2022 (%)
by Treatment Type
Respiratory Support
Circulatory Support.
Convalescent Plasma Therapy
Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin)
Antimicrobial Therapy
Renal Failure and Renal Replacement Therapy
Lung Replacement Therapy
Immunotherapy
Other therapeutic measures
by Severity Degree
Light
Ordinary
Heavy
Critical
Convalescence
Global Covid-19 Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Covid-19 Treatment Market Segment Percentages, by Application, 2022 (%)
Children
Adult
Special Groups
Global Covid-19 Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Covid-19 Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Covid-19 Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Covid-19 Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Applied DNA Sciences, Inc
Codagenix
GeoVax Labs, Inc.
Takis Biotech
Evvivax
Zydus Cadila
MIGAL Galilee Research Institute
Generex Biotechnology Corporation
Moderna Therapeutics
Novavax
Bravovax
Ascletis Pharma
Janssen Pharmaceuticals
Altimmune
Greffex Inc.
CanSino Biologics, Inc.
ExpreS2ion Biotechnologies ApS
Clover Biopharmaceuticals
Vaxil Bio Ltd.
iBio Pharma Inc
Tonix Pharmaceuticals
Curevac
ImmunoPrecise
Outline of Major Chapters:
Chapter 1: Introduces the definition of Covid-19 Treatment, market overview.
Chapter 2: Global Covid-19 Treatment market size in revenue.
Chapter 3: Detailed analysis of Covid-19 Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Covid-19 Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.